Rebeccamycin

Rebeccamycin

SCHEMBL30194716

CO[C@H]1[C@H](O)[C@@H](O)[C@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)O[C@@H]1CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 1.00
▸ PAX8 Q06710 1/20 1.00
▸ PRKCA P17252 10/20 0.84
▸ PRKD3 O94806 1/20 0.80
▸ PRKCG P05129 1/20 0.80
▸ PRKCB P05771 1/20 0.80
▸ PRKCH P24723 1/20 0.80
▸ PRKCI P41743 1/20 0.80
▸ PRKCE Q02156 1/20 0.80
▸ PRKCQ Q04759 1/20 0.80
▸ PRKCZ Q05513 1/20 0.80
▸ PRKCD Q05655 1/20 0.80
▸ PRKD1 Q15139 1/20 0.80
▸ TOP1 P11387 12/20 0.62
▸ EGFR P00533 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rebeccamycin SCHEMBL14069957 1.00 DYRK1A (1.00) DYRK1APAX8PRKCAPRKD3PRKCG
Rebeccamycin SCHEMBL24695 1.00 DYRK1A (1.00) DYRK1APAX8PRKCAPRKD3PRKCG
Rebeccamycin SCHEMBL12961242 1.00 DYRK1A (1.00) DYRK1APAX8PRKCAPRKD3PRKCG
Rebeccamycin SCHEMBL32690193 1.00 DYRK1A (1.00) DYRK1APAX8PRKCAPRKD3PRKCG
SCHEMBL10027492 0.89 DYRK1A (0.81) DYRK1APAX8PRKCAPRKD3PRKCG
SCHEMBL7165791 0.86 DYRK1A (0.76) DYRK1APAX8PRKCAPRKD3PRKCG
Rebeccamycin SCHEMBL19100060 0.86 DYRK1A (0.75) DYRK1APAX8PRKCAPRKD3PRKCG
Becatecarin SCHEMBL5953888 0.85 PRKCA (0.78) DYRK1APAX8PRKCAPRKD3PRKCG
Becatecarin SCHEMBL5953787 0.85 PRKCA (0.78) DYRK1APAX8PRKCAPRKD3PRKCG
Becatecarin SCHEMBL31237559 0.85 PRKCA (0.78) DYRK1APAX8PRKCAPRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024241248-A1 COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES INNOPHARMASCREEN INC. (KR) 2024-11-28 — — WO disclosed
EP-4392449-A1 ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73 Universitätsklinikum Hamburg-Eppendorf (DE) 2024-07-03 — — EP disclosed
EP-4388003-A1 ANTIGEN-BINDING POLYPEPTIDES AGAINST CD39 Universitätsklinikum Hamburg-Eppendorf (DE) 2024-06-26 — — EP disclosed
WO-2023021185-A1 ANTIGEN-BINDING POLYPEPTIDES AGAINST CD39 Universitätsklinikum Hamburg-Eppendorf (DE) 2023-02-23 — — WO disclosed
WO-2023021186-A1 ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73 Universitätsklinikum Hamburg-Eppendorf (DE) 2023-02-23 — — WO disclosed
Send feedback